无细胞疗法：治疗新冠肺炎的新方法。 - Suppr

Suppr

超能文献

Cell-Free Therapies: Novel Approaches for COVID-19.

作者信息

Maron-Gutierrez Tatiana, Rocco Patricia R M

机构信息

Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.

National Institute of Science and Technology for Neuroimmunomodulation, Rio de Janeiro, Brazil.

出版信息

Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.

DOI:10.3389/fimmu.2020.583017

PMID:33072130

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7530633/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/282c/7530633/a58d2340f323/fimmu-11-583017-g0001.jpg

相似文献

Cell-Free Therapies: Novel Approaches for COVID-19.

Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.

Introduction: Finding a way in daily clinical practice during COVID-19 pandemic.

Eur J Clin Invest. 2020 Jul;50(7):e13329. doi: 10.1111/eci.13329.

COVID-19 and the newly rediscovered multidisciplinarity.

Immunotherapy. 2020 Oct;12(15):1101-1103. doi: 10.2217/imt-2020-0205. Epub 2020 Sep 21.

Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.

JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.

COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression.

CNS Neurosci Ther. 2020 Aug;26(8):876-878. doi: 10.1111/cns.13431.

[Not Available].

Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.

Immunopathogenesis of COVID-19: Summary and Possible Interventions.

Front Immunol. 2020 Sep 17;11:564925. doi: 10.3389/fimmu.2020.564925. eCollection 2020.

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.

Eur J Epidemiol. 2020 Apr;35(4):331-333. doi: 10.1007/s10654-020-00635-2. Epub 2020 Apr 21.

Lymphopenia in COVID-19: Therapeutic opportunities.

Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3.

Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.

Cancer Immunol Immunother. 2020 Jun;69(6):911-912. doi: 10.1007/s00262-020-02580-1.

引用本文的文献

Extracellular Vesicles from Different Sources of Mesenchymal Stromal Cells Have Distinct Effects on Lung and Distal Organs in Experimental Sepsis.

Int J Mol Sci. 2023 May 4;24(9):8234. doi: 10.3390/ijms24098234.

Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19.

Cells. 2022 Jul 27;11(15):2319. doi: 10.3390/cells11152319.

Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges.

Intensive Care Med Exp. 2021 Dec 31;9(1):61. doi: 10.1186/s40635-021-00424-5.

COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.

Front Cell Dev Biol. 2021 Jun 14;9:675310. doi: 10.3389/fcell.2021.675310. eCollection 2021.

New perspectives for mesenchymal stromal cells as an adjuvant therapy for infectious disease-associated encephalopathies.

Neural Regen Res. 2022 Jan;17(1):48-52. doi: 10.4103/1673-5374.314292.

本文引用的文献

Dexamethasone in Hospitalized Patients with Covid-19.

N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

Is a "Cytokine Storm" Relevant to COVID-19?

JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.

Front Bioeng Biotechnol. 2020 May 26;8:554. doi: 10.3389/fbioe.2020.00554. eCollection 2020.

Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.

Expert Rev Respir Med. 2020 Sep;14(9):865-868. doi: 10.1080/17476348.2020.1778470. Epub 2020 Jun 22.

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies.

Cytotherapy. 2020 Sep;22(9):474-481. doi: 10.1016/j.jcyt.2020.04.100. Epub 2020 May 7.

Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.

Stem Cell Rev Rep. 2021 Feb;17(1):163-175. doi: 10.1007/s12015-020-09994-5.

The role of extracellular vesicles in COVID-19 virus infection.

Infect Genet Evol. 2020 Nov;85:104422. doi: 10.1016/j.meegid.2020.104422. Epub 2020 Jun 13.

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.

J Leukoc Biol. 2020 Jul;108(1):17-41. doi: 10.1002/JLB.3COVR0520-272R. Epub 2020 Jun 13.

Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.

Stem Cells Dev. 2020 Jul;29(14):877-878. doi: 10.1089/scd.2020.0089. Epub 2020 Jun 10.

The involvement of the central nervous system in patients with COVID-19.

Rev Neurosci. 2020 May 26;31(4):453-456. doi: 10.1515/revneuro-2020-0026.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Cell-Free Therapies: Novel Approaches for COVID-19.

Front Immunol. 2020 Sep 18;11:583017. doi: 10.3389/fimmu.2020.583017. eCollection 2020.

Introduction: Finding a way in daily clinical practice during COVID-19 pandemic.

Eur J Clin Invest. 2020 Jul;50(7):e13329. doi: 10.1111/eci.13329.

COVID-19 and the newly rediscovered multidisciplinarity.

Immunotherapy. 2020 Oct;12(15):1101-1103. doi: 10.2217/imt-2020-0205. Epub 2020 Sep 21.

Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.

JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367.

COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression.

CNS Neurosci Ther. 2020 Aug;26(8):876-878. doi: 10.1111/cns.13431.

[Not Available].

Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.

Immunopathogenesis of COVID-19: Summary and Possible Interventions.

Front Immunol. 2020 Sep 17;11:564925. doi: 10.3389/fimmu.2020.564925. eCollection 2020.

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity.

Eur J Epidemiol. 2020 Apr;35(4):331-333. doi: 10.1007/s10654-020-00635-2. Epub 2020 Apr 21.

Lymphopenia in COVID-19: Therapeutic opportunities.

Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3.

Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.

Cancer Immunol Immunother. 2020 Jun;69(6):911-912. doi: 10.1007/s00262-020-02580-1.

引用本文的文献

Extracellular Vesicles from Different Sources of Mesenchymal Stromal Cells Have Distinct Effects on Lung and Distal Organs in Experimental Sepsis.

Int J Mol Sci. 2023 May 4;24(9):8234. doi: 10.3390/ijms24098234.

Potential Cell-Based and Cell-Free Therapy for Patients with COVID-19.

Cells. 2022 Jul 27;11(15):2319. doi: 10.3390/cells11152319.

Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges.

Intensive Care Med Exp. 2021 Dec 31;9(1):61. doi: 10.1186/s40635-021-00424-5.

COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions.

Front Cell Dev Biol. 2021 Jun 14;9:675310. doi: 10.3389/fcell.2021.675310. eCollection 2021.

New perspectives for mesenchymal stromal cells as an adjuvant therapy for infectious disease-associated encephalopathies.

Neural Regen Res. 2022 Jan;17(1):48-52. doi: 10.4103/1673-5374.314292.

本文引用的文献

Dexamethasone in Hospitalized Patients with Covid-19.

N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.

Is a "Cytokine Storm" Relevant to COVID-19?

JAMA Intern Med. 2020 Sep 1;180(9):1152-1154. doi: 10.1001/jamainternmed.2020.3313.

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections.

Front Bioeng Biotechnol. 2020 May 26;8:554. doi: 10.3389/fbioe.2020.00554. eCollection 2020.

Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.

Expert Rev Respir Med. 2020 Sep;14(9):865-868. doi: 10.1080/17476348.2020.1778470. Epub 2020 Jun 22.

Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies.

Cytotherapy. 2020 Sep;22(9):474-481. doi: 10.1016/j.jcyt.2020.04.100. Epub 2020 May 7.

Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.

Stem Cell Rev Rep. 2021 Feb;17(1):163-175. doi: 10.1007/s12015-020-09994-5.

The role of extracellular vesicles in COVID-19 virus infection.

Infect Genet Evol. 2020 Nov;85:104422. doi: 10.1016/j.meegid.2020.104422. Epub 2020 Jun 13.

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.

J Leukoc Biol. 2020 Jul;108(1):17-41. doi: 10.1002/JLB.3COVR0520-272R. Epub 2020 Jun 13.

Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.

Stem Cells Dev. 2020 Jul;29(14):877-878. doi: 10.1089/scd.2020.0089. Epub 2020 Jun 10.

The involvement of the central nervous system in patients with COVID-19.

Rev Neurosci. 2020 May 26;31(4):453-456. doi: 10.1515/revneuro-2020-0026.